Lv1
80 积分 2023-11-18 加入
Targeting the BCKDK/BCLAF1/MYC/HK2 axis to alter aerobic glycolysis and overcome Trametinib resistance in lung cancer
2个月前
已完结
ALK-driven NSCLC: A narrative review - Part I
4个月前
已关闭
Targeting the BCKDK/BCLAF1/MYC/HK2 axis to alter aerobic glycolysis and overcome Trametinib resistance in lung cancer
10个月前
已完结
Inhibition of glycolysis and SIRT1/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells
1年前
已完结